IB-Stat Interactions
There are 207 drugs known to interact with IB-Stat (hyoscyamine), along with 19 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 5 are major, 185 are moderate, and 17 are minor.
- View all 207 medications that may interact with IB-Stat
- View IB-Stat alcohol/food interactions (2)
- View IB-Stat disease interactions (19)
Most frequently checked interactions
View interaction reports for IB-Stat (hyoscyamine) and the medicines listed below.
- alprazolam
- Antivert (meclizine)
- artichoke
- ashwaganda
- B 100 Complex (multivitamin)
- biotin
- CoQ10 (ubiquinone)
- Desyrel (trazodone)
- Estradiol Patch (estradiol)
- etodolac
- fluticasone nasal
- Ginger Root (ginger)
- ibuprofen
- magnesium carbonate
- metaxalone
- montelukast
- Mucinex DM (dextromethorphan / guaifenesin)
- omeprazole
- pantothenate
- propolis
- Q-Sorb Co Q-10 (ubiquinone)
- SudoGest (pseudoephedrine)
- Tums Extra Strength 750 (calcium carbonate)
- Tylenol (acetaminophen)
- venlafaxine
- Vitamin C with Rose Hips (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- zolpidem
IB-Stat alcohol/food interactions
There are 2 alcohol/food interactions with IB-Stat (hyoscyamine).
IB-Stat disease interactions
There are 19 disease interactions with IB-Stat (hyoscyamine) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- hypertension
- hyperthyroidism
- diarrhea
- fever
More about IB-Stat (hyoscyamine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: anticholinergics/antispasmodics
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.